Group One Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-40,500
| Closed | -$6.97M | – | 9191 |
|
|
2021
Q3 | $6.97M | Buy |
+40,500
| New | +$5.3M | 0.01% | 1385 |
|
|
2021
Q2 | – | Sell |
-10,200
| Closed | -$1.38M | – | 8792 |
|
|
2021
Q1 | $1.38M | Buy |
10,200
+4,900
| +92% | +$633K | ﹤0.01% | 2865 |
|
|
2020
Q4 | $678K | Sell |
5,300
-27,100
| -84% | -$3.18M | ﹤0.01% | 3007 |
|
|
2020
Q3 | $3.65M | Buy |
32,400
+23,100
| +248% | +$2.3M | 0.01% | 1129 |
|
|
2020
Q2 | $886K | Sell |
9,300
-3,500
| -27% | -$337K | ﹤0.01% | 2141 |
|
|
2020
Q1 | $1.15M | Sell |
12,800
-600
| -4% | -$46.6K | 0.01% | 1420 |
|
|
2019
Q4 | $710K | Buy |
13,400
+13,300
| +13,300% | +$606K | ﹤0.01% | 2154 |
|
|
2019
Q3 | $4K | Sell |
100
-2,900
| -97% | -$126K | ﹤0.01% | 4836 |
|
|
2019
Q2 | $123K | Sell |
3,000
-1,200
| -29% | -$49.7K | ﹤0.01% | 3187 |
|
|
2019
Q1 | $196K | Buy |
4,200
+300
| +8% | +$13.2K | ﹤0.01% | 2726 |
|
|
2018
Q4 | $170K | Sell |
3,900
-14,800
| -79% | -$739K | ﹤0.01% | 2809 |
|
|
2018
Q3 | $1.07M | Sell |
18,700
-59,400
| -76% | -$2.92M | 0.01% | 1655 |
|
|
2018
Q2 | $3.79M | Buy |
78,100
+59,700
| +324% | +$2.18M | 0.03% | 692 |
|
|
2018
Q1 | $719K | Buy |
18,400
+7,400
| +67% | +$315K | 0.01% | 1755 |
|
|
2017
Q4 | $467K | Buy |
11,000
+9,300
| +547% | +$349K | ﹤0.01% | 2312 |
|
|
2017
Q3 | $63K | Sell |
1,700
-10,200
| -86% | -$354K | ﹤0.01% | 3516 |
|
|
2017
Q2 | $362K | Buy |
11,900
+9,100
| +325% | +$264K | ﹤0.01% | 2201 |
|
|
2017
Q1 | $74K | Buy |
+2,800
| New | +$73.8K | ﹤0.01% | 3178 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$5K | – | 5130 |
|
|
2015
Q4 | $5K | Sell |
100
-2,000
| -95% | -$72K | ﹤0.01% | 4384 |
|
|
2015
Q3 | $52K | Buy |
2,100
+100
| +5% | +$3.01K | ﹤0.01% | 3511 |
|
|
2015
Q2 | $63K | Buy |
2,000
+1,500
| +300% | +$48.4K | ﹤0.01% | 3399 |
|
|
2015
Q1 | $19K | Sell |
500
-22,400
| -98% | -$891K | ﹤0.01% | 3919 |
|
|
2014
Q4 | $892K | Buy |
22,900
+10,200
| +80% | +$355K | 0.01% | 1142 |
|
|
2014
Q3 | $384K | Buy |
12,700
+2,700
| +27% | +$76.1K | 0.01% | 1809 |
|
|
2014
Q2 | $340K | Buy |
+10,000
| New | +$334K | 0.01% | 1964 |
|
Group One Trading's XLRN Position: Q4 2021 in Review
Group One Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 21,002 shares — an estimated $3.61M sold.
Group One Trading first reported a position in XLRN in Q3 2014 and held it in 9 quarters. The position peaked at $3.61M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Group One Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 21,002 Acceleron Pharma shares in Q4 2021, an estimated $3.61M.
- Group One Trading first reported a position in Acceleron Pharma in Q3 2014 and held it in 9 quarters.
- Group One Trading's Acceleron Pharma position peaked at $3.61M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.